CN109805940A - Blood sugar monitoring control system - Google Patents
Blood sugar monitoring control system Download PDFInfo
- Publication number
- CN109805940A CN109805940A CN201711160713.4A CN201711160713A CN109805940A CN 109805940 A CN109805940 A CN 109805940A CN 201711160713 A CN201711160713 A CN 201711160713A CN 109805940 A CN109805940 A CN 109805940A
- Authority
- CN
- China
- Prior art keywords
- liquid
- monitoring control
- control system
- blood sugar
- holder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A kind of blood sugar monitoring control system, include: a detection device and a liquid feed device, detection device can detect the blood-sugar content of user through the tissue fluid of detection user at any time, when the blood-sugar content exception of user, detection device just starts liquid feed device, so that liquid feed device horse back infusing insulin liquid is entered with user, adjust user's blood-sugar content, enables the blood-sugar content of user can be for a long time in the state of stablizing.
Description
[technical field]
This case is about a kind of blood sugar monitoring control system, and espespecially one kind can monitor control blood sugar for human body content for a long time
Blood sugar monitoring control system.
[background technique]
The diabetic that self is detected as of blood glucose plays a very important role in management blood glucose, but is used at present
The blood glucose machine for measuring blood glucose is all not readily portable, therefore patient is difficult to detect blood-sugar content in outgoing time-varying, and in measurement blood
In the process of sugar, acupuncture treatment is had sometimes but non-bleeding or the very little situation of blood volume, it is therefore desirable to have an acupuncture treatment or firmly squeeze again
Blood out, but acupuncture treatment may cause burden of patients again, and firmly it is inaccurate may to will lead to measurement result again for extrusion blood.In addition,
When Finding case blood glucose occurs abnormal, the horse back for being difficult instantaneity takes oral medicine or injection, and will lead to blood glucose can not grow
The state that it is fixed that time dimension keeps steady, easily causes complication, further endangers the body of patient.
For above-mentioned missing, a kind of safe, easy to carry, painless intelligent blood sugar monitoring control system is developed in this case,
There is provided patient in daily life can at any time, easily measure blood-sugar content, and can long-time stable blood-sugar content, solve to suffer from
Person can not stabilizing blood sugar the problem of.
[summary of the invention]
It is carried to solve the problems, such as that traditional insulin injections will cause patient pain with inconvenience, this case provides
A kind of blood sugar monitoring control system includes: a detection device, include one first microneedle patch, one draw liquid actuator, one sensing
Device and a monitoring control chip, wherein first microneedle patch has multiple empty micropins, attaches insertion human skin to draw
One tissue fluid, this draws liquid actuator and is equipped with a liquid-conveying ducts and one first actuating unit, the liquid-conveying ducts and first microneedle patch
Piece connection, first actuating unit make the liquid-conveying ducts form pressure difference to draw the tissue fluid to activate, and also make the drain logical
Road draws the tissue fluid imported by multiple empty micropin, and the sensor is set in the liquid-conveying ducts, should with monitoring
Blood-sugar content numerical value in tissue fluid, and send monitoring control chip interpretation to and calculate a blood glucose numerical information, and sending should
The notice of blood glucose numerical information；And a liquid feed device, it include one second microneedle patch, a feed flow actuator, one for liquid chamber
And one feed flow control chip, wherein second microneedle patch have multiple empty micropins, for attach insertion human skin in, the confession
Liquid actuator is equipped with a reservoir channel and one second actuating unit, which is connected to second microneedle patch, and with this
It is connected to for liquid chamber, and this stores an insulin fluid for liquid chamber, second actuating unit is with the progress of the actuating compression reservoir channel
Liquid transmission, and feed flow control chip receives the blood glucose numerical information transmitted by the monitoring control chip of the detection device
Notice makes the reservoir channel form pressure difference and transmits this for stored by liquid chamber to activate the second actuating unit of the liquid feed device
The insulin fluid, and it is directed into multiple empty micropin, to inject the insulin fluid into the subcutaneous tissue of human body, in order to control
The required balance of blood glucose processed.
[Detailed description of the invention]
Fig. 1 is the use schematic diagram of the blood sugar monitoring control system of this case.
Fig. 2 is the structure of the detecting device schematic diagram of the blood sugar monitoring control system of this case.
Fig. 3 is the liquid feed device structural schematic diagram of the blood sugar monitoring control system of this case.
Fig. 4 is the valve structure schematic diagram of the blood sugar monitoring control system of this case.
Fig. 5 A, Fig. 5 B are the illustrative view for the blood sugar detection apparatus that Fig. 2 show this case blood sugar monitoring control system.
Fig. 6 A, Fig. 6 B are the liquid feed device illustrative view that Fig. 3 show this case blood sugar monitoring control system.
Fig. 7 A, Fig. 7 B are the threshold switch illustrative view of the blood sugar monitoring control system of this case.
Fig. 8 is the block schematic diagram of the related elements electrical connection relationship of this case blood sugar monitoring control system.
[symbol description]
100: blood sugar monitoring control system
1: detection device
11: the first microneedle patch
111: empty micropin
12: drawing liquid actuator
121: liquid-conveying ducts
121a: access road
121b: liquid storage channel
122: the first actuating units
123: first vector
124: first pressure chamber
125: fluid reservoir
126a, 126b: the first projective structure
13: sensor
14: monitoring control prison piece
141: sending transmission module
2: liquid feed device
21: the second microneedle patch
211: empty micropin
22: feed flow actuator
221: reservoir channel
221a: liquid outlet channel
221b: liquid-conveying ducts
222: the second actuating units
223: Second support
224: second pressure chamber
226a, 226b: the second projective structure
23: for liquid chamber
24: feed flow controls chip
241: receiving transmission module
3: valve block
31: valve opening
32: central portion
33: interconnecting piece
4: threshold switch
41: holder
42: sealing element
43: displacement piece
44: through-hole
[specific embodiment]
The some exemplary embodiments for embodying this case features and advantages will describe in detail in the explanation of back segment.It should be understood that
This case can have various variations in different aspects, all not depart from the range of this case, and explanation therein and diagram
It is inherently illustrated as being used, and nand architecture is in limitation this case.
This case is a kind of blood sugar monitoring control system, is please referred to Fig.1 to Fig.3, as shown in Figure 1, blood sugar monitoring control system
100 include a detection device 1 and a liquid feed device 2；As shown in Fig. 2, detection device 1 includes one first microneedle patch 11, one
Draw liquid actuator 12, a sensor 13 and a monitoring control chip 14；As shown in figure 3, then to contain one second micro- for liquid feed device 2
Needle patch 21, a feed flow actuator 22, one control chip 24 for liquid chamber 23 and a feed flow, and this case is detected through detection device 1
The blood-sugar content of user, and insulin fluid is provided by liquid feed device 2, when detection device 1 detects that the blood glucose of user contains
When amount is abnormal, liquid feed device 2, which will start, injects insulin fluid in user's body, to reach blood sugar monitoring, control
Purpose.
Please continue to refer to shown in Fig. 1 and Fig. 2, the liquid actuator 12 that draws of the detection device 1 of this case contains a liquid-conveying ducts
121, one first actuating unit 122, a first vector 123, first pressure chamber 124 and fluid reservoir 125, in first vector 123
Fovea superior is set to form a first pressure chamber 124, a fluid reservoir 125, a liquid-conveying ducts 121, and liquid-conveying ducts 121 have further included one and entered
Mouth channel 121a and a liquid storage channel 121b, the two are set in first vector 123 with being spaced from each other, and penetrate First pressure chamber
Room 124 is connected, and liquid storage channel 121b is connected to fluid reservoir 125, and sensor 13 is then set in fluid reservoir 125, to examine
Survey the liquid being stored in fluid reservoir 125；And 122 framework of the first actuating unit is in first vector 123, and covers first pressure
Chamber 124 generates one and draws power, for extracting liquid after the first 122 actuation of actuating unit；First microneedle patch 11 attaches
It in first vector 123, and is communicated with access road 121a, and there are multiple empty micropins 111, multiple empty micropins 111 are thoroughly
Cross noninvasive or minimally invasive insertion human skin；And sensor 13 and monitoring control chip 14 adopt micro electronmechanical processing procedure (MEMS) and are integrated in the
On one carrier 12 3, sensor 13 is packaged in first vector 123 through system, and monitoring control chip 14 is equally encapsulated with system
It is set in first vector 123, to control the starting and the number that is monitored of reception, analyte sensors 13 that draw liquid actuator 12
According to.The above-mentioned liquid actuator 12 that draws penetrates 122 lidstock pressure chamber 124 of the first actuating unit, activates via driving first
Unit 122 vibrates up and down, and changes the volume of first pressure chamber 124, the pressure inside first pressure chamber 124 is made to change
And then it generates and draws power.
It please refers to shown in Fig. 1 and Fig. 8, in this present embodiment, when multiple empty micropins 111 of the first microneedle patch 11 are pierced into
After human body, monitoring control chip 14 will drive 122 vertical vibration of the first actuating unit for drawing liquid actuator 12, cause through first
The expansion of moving cell 122, the volume for compressing first pressure chamber 124 change internal pressure to generate and draw power, in access road
121a generates suction, and the tissue fluid of human body is sucked through the empty micropin 111 of the first microneedle patch 11, flows through first pressure chamber
124 and liquid storage channel 121b enters inside fluid reservoir 125, at this point, sensor 13 will detect blood-sugar content numerical value in tissue fluid,
And send monitoring control 14 interpretation of chip to and calculate blood glucose numerical information, this external monitor, which controls chip 14, has one to send transmission
Module 141, for transmitting the notice of blood glucose numerical information.Wherein, above-mentioned tissue fluid is the subcutaneous tissue fluid of human body, and feed flow
Device 2 also has one to receive transmission module 24, for monitoring control the transmitted blood glucose numerical value of chip 14 letter of receiving detection device 1
The notice of breath enables feed flow control chip 24 to start feed flow actuator 22 rapidly, to be transmitted in for the insulin in liquid chamber 23
Liquid, and the body of user is injected, enable the blood-sugar content of user that can stablize.
It please refers to shown in Fig. 1 and Fig. 3, the feed flow actuator 22 of this case liquid feed device 2 contains a reservoir channel 221, one
Second actuating unit 222, a Second support 223 and second pressure chamber 224, set to form one second in 223 fovea superior of Second support
Pressure chamber 224, a reservoir channel 221, reservoir channel 221 have further included an a liquid outlet channel 221a and liquid-conveying ducts 221b,
The two is set on Second support 223 with being spaced from each other, and is connected through second pressure chamber 224, and liquid-conveying ducts 221b
It is connected to for liquid chamber 23, for storing insulin fluid in liquid chamber 23, and there is feed flow outlet 231,231 setting one of feed flow outlet
Threshold switch 4 flows out to control insulin fluid；Second microneedle patch 21 is attached on Second support 223, and and liquid outlet channel
221a is communicated, and has multiple empty micropins 211, multiple empty micropins 211 through noninvasive or minimally invasive insertion human skin come for
Infusing insulin liquid；And feed flow control chip 24 is adopted micro electronmechanical processing procedure (MEMS) and is integrated on Second support 223 to control
The starting of feed flow actuator 22, furthermore feed flow control chip 24 has one to receive transmission module 241 (as shown in Figure 8), to connect
Receive the blood glucose numerical information that the transmission transmission module 141 of the monitoring control chip 14 of detection device 1 is transmitted.Above-mentioned feed flow causes
Dynamic device 22 penetrates 222 lidstock second pressure chamber 224 of the second actuating unit, vibrates up and down via the second actuating unit 222
Actuation driving and change the volume of second pressure chamber 224, make pressure second pressure chamber 224 inside that pressure difference change occur
Change and then generate expulsion force and is used to be sent discharge insulin fluid.
It please refers to shown in Fig. 1 and Fig. 3, in this present embodiment, when multiple empty micropins 211 of the second microneedle patch 21 are pierced into
After human body, feed flow control chip 24 will drive 222 vertical vibration of the second actuating unit for fluid brake 22, through the second system
The expansion of moving cell 222, the volume for compressing second pressure chamber 224 change internal pressure and generate pressure difference variation to generate discharge
Insulin fluid in fluid reservoir 125 is entered the second microneedle patch by second pressure chamber 224 and reservoir channel 221 by power
21, and injected insulin fluid in user by multiple empty micropins 211 in the second microneedle patch 21.
Multiple empty micropins 111 of the first above-mentioned microneedle patch 11 or multiple empty micropins of the second microneedle patch 21
211 be all the micron order size pinholes that can pierce through skin, and material can be high molecular polymer, metal or silicon, preferably for tool
The silica of high-biocompatibility, the pore size of empty micropin 111,211 are to pass through for insulin molecule, preferably,
The internal diameter of empty micropin 111,211 between 10 microns (μm) to 550 microns (μm), the length of empty micropin 111,211 be between
400 microns (μm) to 900 microns (μm), it can be inserted into the subcutaneous tissue of human body and be pierced into depth and do not touch human nerve, therefore is complete
It not will cause pain entirely.Wherein, multiple empty micropins 111,211 adopt respectively with array manner be arranged in the first microneedle patch 11 with
It is unlikely to influence each other from need to be greater than 200 microns between each empty micropin 111,211 is adjacent in second microneedle patch 21
The interference of water conservancy diversion, multiple empty micropins 111,211 of such array manner setting, do not have wherein a needle empty micropin 111,
211 blockings influence the function of injection fluid, in addition, the effect injected or drawn can be done by multiple empty micropins 111,211.
Please continue to refer to Fig. 2 and Fig. 4, the detection device 1 of blood sugar monitoring control system 100 can be in access road 121a and storage
A valve block 3 is respectively set in liquid channel 121b, multiple valve openings 31 is formed on valve block 3, and first vector 123 is in access road 121a
It is respectively arranged with one first protrusion structure 126a, 126b with liquid storage channel 121b, is provided with first in access road 121a
The first protrusion structure 126b protrusion direction of protrusion structure 126a and liquid storage channel 121b on the contrary, in this present embodiment, be located at into
The first protrusion structure 126a of mouthful channel 121a be it is protruding upward, in the first protrusion structure 126b of liquid storage channel 121b be downward
Protrusion, and valve block 3 offers multiple valve openings 31 in corresponding access road 121a and the liquid storage channel partial region 121b, and is equipped with one
Central portion 32 is connected by multiple interconnecting pieces 33, and multiple valve openings 31 are set between multiple intervals of interconnecting piece 33, make interconnecting piece
33, which provide central portion 32, flexibly supports, in this way, the first protrusion knot of above-mentioned access road 121a and liquid storage channel 121b
Structure 126a, 126b are closely against valve block 3, and close its valve opening 31, and generate a prestressing counter-active effect.By above-mentioned setting,
In the first 122 non-actuation of actuating unit, can divide in the central portion 32 of the valve block 3 on access road 121a and liquid storage channel 121b
Access road 121a and liquid storage channel 121b Feng Bi not completely cut off, in this way, which tissue fluid can be prevented in access road 121a and storage
Adverse current occurs for liquid channel 121b.
Please continue to refer to Fig. 3 and Fig. 4, the liquid feed device 2 of blood sugar monitoring control system 100 can also in liquid outlet channel 221a and
A valve block 3 is respectively set in liquid-conveying ducts 221b, multiple valve openings 31 is formed on valve block 3, and Second support 223 is in liquid outlet channel
221a and liquid-conveying ducts 221b are respectively arranged with one second protrusion structure 226a, 226b, are provided in liquid outlet channel 221a's
The second protrusion structure 226b protrusion direction of second protrusion structure 226a and liquid-conveying ducts 221b is on the contrary, in this present embodiment, position
In enter liquid outlet channel 221a the second protrusion structure 226a be it is downwardly projecting, in the second protrusion structure 226b of liquid-conveying ducts 221b
To be protruding upward, and liquid outlet channel 221a is same as the partial region liquid-conveying ducts 221b offers multiple valve openings corresponding for valve block 3
31, and be equipped with a central portion 32 and connected by multiple interconnecting pieces 33, and multiple valve openings 31 are set to multiple 33 intervals of interconnecting piece
Between, so that interconnecting piece 33 is provided central portion 32 and flexibly supports, in this way, above-mentioned liquid outlet channel 221a and liquid-conveying ducts 221b
Second projective structure 226a, 226b is closely against valve block 3, and closes its valve opening 31, and generates a prestressing counter-active effect.By
Above-mentioned setting, in the second 222 non-actuation of actuating unit, in the valve block 3 on liquid outlet channel 221a and liquid-conveying ducts 221b
Centre portion 32 can close off isolation liquid outlet channel 221a and liquid-conveying ducts 221b, in this way, which insulin fluid can be prevented in out
Adverse current occurs for liquid channel 221a and liquid-conveying ducts 221b.
Please referring to Fig. 5 A and Fig. 5 B, detection device 1 is drawn after liquid actuator 12 is monitored the control control starting of chip 14,
First actuating unit 122 just starts bending vibration up and down, first as shown in Figure 5A, when the first actuating unit 122 shifts up, the
The volume of one pressure chamber 124 increases, and produces negative pressure and then the valve block 3 of access road 121a is driven to shift up, make its valve
The valve opening 31 of piece 3 the first protrusion structure 126a of disengaging (as shown in Figure 4), at this point, access road 121a and first pressure chamber 124
Connection produces access road 121a and draws since 124 volume of first pressure chamber increases the relationship for generating pressure difference and changing
Power, the microneedle patch 11 being so connected to access road 121a, which also generates, to be drawn power and draws in tissue fluid enters, and tissue fluid is enabled to pass through
Access road 121a enters in first pressure chamber 124, then as shown in Figure 5 B, and monitoring control chip 14 continues output drive signal
To liquid actuator 12 is drawn, the first actuating unit 122 is to bottom offset, at this point, the volume of first pressure chamber 124, which reduces, generates pressure
Difference variation, produces positive pressure expulsion and moves down in the valve block 3 in the 121b of liquid storage channel, and its valve opening 31 is made to be detached from the first protrusion
Structure 126b, the tissue fluid in first pressure chamber 124 will be pushed in the 121b of liquid storage channel by positive pressure, finally enter storage
Liquid chamber 125, such tissue fluid are sent to monitoring control chip by blood-sugar content numerical value in the detection tissue fluid of sensor 13
14 interpretations calculate blood glucose numerical information, when need to supplement insulin if the display of blood glucose numerical information is abnormal, as shown in figure 8, inspection
The notice of blood glucose numerical information can be sent to liquid feed device by the transmission transmission module 141 of monitoring control chip 14 by surveying device 1
2, start the fluid injection operation of liquid feed device 2, user is allowed to supplement insulin.
It is please referred to shown in Fig. 6 A, Fig. 6 B and Fig. 8 again, when the monitoring for receiving detection device 1 of liquid feed device 2 controls chip
The notice of 14 transmitted blood glucose numerical informations enables feed flow control chip 24 to start feed flow actuator 22, the second actuating rapidly
Unit 222 just starts bending vibration up and down, first as shown in Figure 6A, when the second actuating unit 222 shifts up, second pressure chamber
The volume of room 224 increases and pressure difference changes, and produces negative pressure and then the valve block 3 of liquid-conveying ducts 221b is driven to shift up, make
The valve opening 31 of its valve block 3 the second protrusion structure 226a of disengaging (as shown in Figure 4), at this point, liquid-conveying ducts 221b and second pressure chamber
Room 224 is connected to, and the relationship of pressure difference variation is generated due to the increase of 224 volume of second pressure chamber, produces liquid-conveying ducts 221b
Given birth to and drawn power, and feed flow control chip 24 control feed flow outlet 231 threshold switch 4 open, so with liquid-conveying ducts 221b phase
Logical is drawn for the insulin fluid in liquid chamber 23, and insulin fluid is made to enter second pressure chamber by liquid-conveying ducts 221b
In 224, then as shown in Figure 6B, feed flow control chip 24 continues output drive signal to feed flow actuator 22, the second actuating unit
222 produce positive pressure expulsion in liquid out at this point, the volume of second pressure chamber 224, which reduces, generates pressure difference variation to bottom offset
Valve block 3 in the 221a of channel moves down, and makes the valve opening 31 of its valve block 3 the second protrusion structure 226b of disengaging (as shown in Figure 4),
Insulin fluid in second pressure chamber 224 will be pushed into liquid-conveying ducts 221a by positive pressure, then via the second microneedle patch
Multiple empty micropins 211 of piece 21 inject insulin fluid in user, enable the blood-sugar content of user that can stablize.
Please continue to refer to Fig. 3 and Fig. 7 A, the threshold switch 4 for liquid chamber 23 of liquid feed device 2 is sealed comprising a holder 41, one
Part 42 and a displacement piece 43.Displacement piece 43 is set between holder 41 and sealing element 42, holder 41, sealing element 42, position
It moves on part and is respectively provided with multiple through-holes 44, and holder 41 and multiple through-holes 44 of displacement piece 43 are mutually aligned, and sealing element 42
It is misaligned with 44 mutual dislocation of multiple through-holes of holder 41.
Please referring initially to Fig. 7 A, displacement piece 43 is an electrically charged material, and holder 41 is a dipolar conductive material,
To enable displacement piece 43 and holder 41 maintain identical polar, and it is close towards the sealing element 42, constitute the closing of the threshold switch 4；Please
Referring again to Fig. 7 B, displacement piece 43 is an electrically charged material, and holder 41 is a dipolar conductive material, to enable displacement piece
43 maintain opposed polarity with holder 41, and close towards holder 41, the unlatching of the threshold switch 4 are constituted, through adjustment holder
41 polarity, to keep displacement piece 43 mobile, to form unlatching/closed state of threshold switch 4.The holder 41 is controlled by the feed flow
Chip 24 controls its polarity.
In addition, the displacement piece 43 of above-mentioned threshold switch 4 can be a magnetic material, and holder 41 controlled can become for one
The magnetic material of polar exchanging, when displacement piece 43 and the maintenance identical polar of holder 41, displacement piece 43 is close towards the sealing element 42,
Close threshold switch 4；Conversely, displacement piece 43 will be towards the holder when holder 41 changes 43 opposed polarity of polarity and displacement
41 is close, constitute the threshold switch 4 unlatching, by it is described above it is known that by adjusting holder 41 magnetism, make displacement piece 43
It is mobile, to adjust unlatching/closed state of threshold switch 4.The holder 41 controls its pole polarity by feed flow control chip 24.
As shown in figure 8, the transmission transmission module 141 of the present embodiment and receive transmission module 241 can via wire transmission,
Such as: the wire transmission module of one of USB, mini-USB, micro-USB, or wireless transmission, such as: Wi-Fi module,
The wireless transport module of one of bluetooth module, radio frequency identification module, a near field communication module etc..
In conclusion blood sugar monitoring control system provided by this case, when the first microneedle patch of detection device is pierced into people
After the subcutaneous tissue of body, barometric gradient is generated through the actuation for drawing liquid actuator, is made multiple hollow micro- in the first microneedle patch
Needle generation draws power to draw the tissue fluid of subcutaneous tissue, then is entered in fluid reservoir by the first actuator, by being located at fluid reservoir
Blood glucose information to parse blood glucose information, and is sent to monitoring control core by the blood-sugar content in interior sensor detection tissue fluid
Piece, when the blood-sugar content of user instantly occurs abnormal, monitoring control chip transmission transmission blood glucose numerical information to feed flow is filled
The feed flow control chip set, enables feed flow control chip to activate feed flow actuator at once, insulin fluid is immediately injected
With user, the stabilization of blood-sugar content is maintained, and the blood sugar monitoring control system of this case can easily, simply, anywhere or anytime
Blood glucose is measured, the puzzlement that user measures blood glucose is reduced, and when blood-sugar content is abnormal, can promptly inject pancreas islet
Plain liquid can maintain the stabilization of blood-sugar content for a long time, and diabetic is overcome for a long time, effectively can not to remain stable at present
Blood glucose.In addition, this case using microneedle patch using it is noninvasive or it is minimally invasive detect blood glucose to obtain the tissue fluid of subcutaneous tissue, can
User's burden is reduced, the generation of wound is avoided and reduces infection risk.
This case appointed as person familiar with the technology apply craftsman think and be it is all as modify, it is so neither de- such as attached claim
Be intended to Protector.
Claims (21)
1. a kind of blood sugar monitoring control system, characterized by comprising:
One detection device, include one first microneedle patch, one draw liquid actuator, a sensor and one monitoring control chip,
In first microneedle patch have multiple empty micropins, attach insertion human skin to draw a tissue fluid, this draws liquid actuator
Equipped with a liquid-conveying ducts and one first actuating unit, which is connected to first microneedle patch, first actuating unit
So that the liquid-conveying ducts is formed pressure difference to draw the tissue fluid with actuating, draws the liquid-conveying ducts by multiple empty micropin
The tissue fluid imported, and the sensor is set in the liquid-conveying ducts, to monitor blood-sugar content numerical value in the tissue fluid, and
It sends monitoring control chip interpretation to and calculates a blood glucose numerical information, and send the notice of the blood glucose numerical information；And
One liquid feed device includes one second microneedle patch, a feed flow actuator, one controls chip for liquid chamber and a feed flow,
In second microneedle patch have multiple empty micropins, for attach insertion human skin in, the feed flow actuator be equipped with a fluid injection
Channel and one second actuating unit, which is connected to second microneedle patch, and is connected to this for liquid chamber, and the feed flow
Room stores an insulin fluid, which carries out liquid transmission with the actuating compression reservoir channel, and this is for hydraulic control
Coremaking piece receives the notice of the blood glucose numerical information transmitted by the monitoring control chip of the detection device, to activate feed flow dress
The second actuating unit set makes the reservoir channel form pressure difference and transmits this for the insulin fluid stored by liquid chamber, and imports
To multiple empty micropin, to inject the insulin fluid into the subcutaneous tissue of human body, in order to the control required balance of blood glucose.
2. blood sugar monitoring control system as described in claim 1, which is characterized in that the detection device this draw liquid actuator into
One step includes a first vector, a first pressure chamber and a fluid reservoir, which includes an access road and one
Liquid storage channel is spaced from each other and provided in the first vector, and the first pressure chamber is connected to the access road and the liquid storage is logical
Road, and the liquid storage channel is connected to the fluid reservoir, and which is set in the fluid reservoir.
3. blood sugar monitoring control system as claimed in claim 2, which is characterized in that first actuating unit covers first pressure
Power chamber for the actuating compression liquid-conveying ducts, and is drawn the tissue fluid by multiple empty micropin and is imported in the fluid reservoir.
4. blood sugar monitoring control system as claimed in claim 2, which is characterized in that monitoring control chip is packaged in system
In the first vector, to control first actuating unit for drawing liquid actuator actuating and receive the monitoring numerical value interpretation of the sensor
The blood glucose numerical information is calculated, and has one to send transmission module, sends the notice of the blood glucose numerical information.
5. blood sugar monitoring control system as claimed in claim 4, which is characterized in that the transmission transmission module is a Wi-Fi mould
At least one wireless transport module of block, a bluetooth module, a radio frequency identification module and a near field communication module.
6. blood sugar monitoring control system as claimed in claim 2, which is characterized in that in the access road and the liquid storage channel into
A valve block is arranged in one step, for controlling the switch state of the access road and the liquid storage channel.
7. blood sugar monitoring control system as claimed in claim 6, which is characterized in that the first vector is in the access road and is somebody's turn to do
There is a protrusion structure at liquid storage channel, contact the valve block to generate a prestressing, to prevent tissue fluid adverse current.
8. blood sugar monitoring control system as described in claim 1, which is characterized in that the feed flow actuator of the liquid feed device into
One step includes a Second support, second pressure chamber and one for liquid chamber, which includes that a liquid outlet channel and one lead
Liquid channel is provided spaced on the Second support, the second pressure chamber liquid outlet channel and the liquid-conveying ducts, and
The liquid-conveying ducts are connected to this for liquid chamber, which covers the second pressure chamber, so that actuating keeps the fluid injection logical
Road forms pressure difference, this is made to be directed into multiple empty micropin for the insulin fluid stored by liquid chamber.
9. blood sugar monitoring control system as claimed in claim 8, which is characterized in that in the liquid outlet channel and the liquid-conveying ducts into
A valve block is arranged in one step, for controlling the switch state of the liquid outlet channel and the liquid-conveying ducts.
10. blood sugar monitoring control system as claimed in claim 9, which is characterized in that the Second support in the liquid outlet channel and
There is a protrusion structure at the liquid-conveying ducts, contact the valve block to generate a prestressing, to prevent insulin fluid adverse current.
11. blood sugar monitoring control system as claimed in claim 8, which is characterized in that the feed flow of the liquid feed device controls core
Piece is packaged on the Second support with system, and has one to receive transmission module, is provided with receiving the monitoring control of the detection device
The notice of the blood glucose numerical information transmitted by coremaking piece, to control second actuating unit for starting the liquid feed device.
12. blood sugar monitoring control system as claimed in claim 11, which is characterized in that the reception transmission module is a Wi-Fi
At least one wireless transport module of module, a bluetooth module, a radio frequency identification module and a near field communication module.
13. blood sugar monitoring control system as described in claim 1, which is characterized in that first microneedle patch and this is second micro-
There is internal diameter between 10 microns to 550 microns in multiple empty micropin of needle patch each, length between 400 microns extremely
900 microns.
14. blood sugar monitoring control system as described in claim 1, which is characterized in that first microneedle patch and this is second micro-
Multiple empty micropin of needle patch is arranged with array manner, and spacing adjacent in multiple empty micropin each is greater than
200 microns.
15. blood sugar monitoring control system as described in claim 1, which is characterized in that first microneedle patch and this is second micro-
Multiple empty micropin of needle patch is made with earth silicon material.
16. blood sugar monitoring control system as described in claim 1, which is characterized in that this is exported for liquid chamber with a feed flow, should
Feed flow outlet is equipped with a threshold switch, which includes a holder, a sealing element and a displacement piece, and wherein the displacement piece is arranged
Multiple through-holes are respectively provided between the holder and the sealing element and in the holder, the sealing element and the displacement piece, and
Multiple lead to the hole site is are mutually aligned on the holder and the displacement piece, and multiple lead to the hole site of the sealing element and the holder
It is misaligned to form dislocation.
17. blood sugar monitoring control system as claimed in claim 16, which is characterized in that the displacement piece is an electrically charged material
Material, and the holder is a dipolar conductive material, to enable the displacement piece and the holder maintain opposed polarity, and towards the guarantor
Gripping member is close, constitutes the unlatching of the threshold switch.
18. blood sugar monitoring control system as claimed in claim 16, which is characterized in that the displacement piece is an electrically charged material
Material, and the holder is a dipolar conductive material, to enable the displacement piece and the holder maintain identical polar, and it is close towards this
Sealing is close, constitutes the closing of the threshold switch.
19. blood sugar monitoring control system as claimed in claim 16, which is characterized in that the displacement piece is a magnetic material
Material, and the holder be one can the polar magnetic material of controlled conversion, to enable the displacement piece and the holder maintain opposed polarity,
And it is close towards the holder, constitute the unlatching of the threshold switch.
20. blood sugar monitoring control system as claimed in claim 16, which is characterized in that the displacement piece is a magnetic material
Material, and the holder be one can the polar magnetic material of controlled conversion, to enable the displacement piece and the holder maintain identical polar,
And it is close towards the sealing element, constitute the closing of the threshold switch.
21. the blood sugar monitoring control system as described in any in claim 17 to 19, which is characterized in that the holder is by this
Feed flow controls its polarity of chip controls.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711160713.4A CN109805940B (en) | 2017-11-20 | 2017-11-20 | Blood sugar monitoring control system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711160713.4A CN109805940B (en) | 2017-11-20 | 2017-11-20 | Blood sugar monitoring control system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109805940A true CN109805940A (en) | 2019-05-28 |
| CN109805940B CN109805940B (en) | 2022-07-12 |
Family
ID=66599208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711160713.4A Active CN109805940B (en) | 2017-11-20 | 2017-11-20 | Blood sugar monitoring control system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109805940B (en) |
Citations (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04150837A (en) * | 1990-10-16 | 1992-05-25 | Nec San-Ei Instr Co Ltd | Blood sugar measuring apparatus |
| JP2007000517A (en) * | 2005-06-27 | 2007-01-11 | National Institute Of Advanced Industrial & Technology | Needle-integrated biosensor |
| CN1973768A (en) * | 2005-11-28 | 2007-06-06 | 中国科学院电子学研究所 | Non-invasive blood sugar instrument for closed-loop insulin injection |
| US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
| CN101377192A (en) * | 2007-08-30 | 2009-03-04 | 研能科技股份有限公司 | Fluid delivery device |
| CN101550925A (en) * | 2008-03-31 | 2009-10-07 | 研能科技股份有限公司 | Fluid transporting device with a plurality of dual-cavity actuating structures |
| US20100262117A1 (en) * | 2007-11-02 | 2010-10-14 | University Of Virginia Patent Foundation | Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing |
| US20110105952A1 (en) * | 2009-10-30 | 2011-05-05 | Seventh Sense Biosystems, Inc. | Relatively small devices applied to the skin, modular systems, and methods of use thereof |
| US20120046651A1 (en) * | 2009-04-17 | 2012-02-23 | Uwe Beyer | Medical device for glucose monitoring or regulation |
| CN203110246U (en) * | 2011-10-28 | 2013-08-07 | 格雷斯海姆·雷根斯堡股份有限公司 | Devices for manufacturing objects with assistance of die-casting tool |
| US20130225956A1 (en) * | 2011-09-23 | 2013-08-29 | National Taipei University Of Technology | Transdermal Sensor |
| TW201335483A (en) * | 2012-02-20 | 2013-09-01 | Microjet Technology Co Ltd | Fluid transmission device |
| CN104114224A (en) * | 2011-09-02 | 2014-10-22 | 加利福尼亚大学董事会 | Microneedle arrays for biosensing and drug delivery |
| US20150202418A1 (en) * | 2012-07-23 | 2015-07-23 | Renephra Limited | Microneedle-based devices and methods for the removal of fluid from a body |
| CN205626630U (en) * | 2016-03-11 | 2016-10-12 | 成都市亿泰科技有限公司 | Portable injection device of intelligence insulin based on cloud calculates |
| CN106390277A (en) * | 2016-09-28 | 2017-02-15 | 成都市亿泰科技有限公司 | Pressure-controlled flexible microneedle drug delivery system |
| TWM537174U (en) * | 2016-01-29 | 2017-02-21 | Microjet Technology Co Ltd | Miniature fluid control device |
| CN107073207A (en) * | 2014-08-01 | 2017-08-18 | 伯克顿迪金森公司 | Continuous glucose monitoring injection device |
| CN208492114U (en) * | 2017-11-20 | 2019-02-15 | 研能科技股份有限公司 | Blood sugar monitoring control system |
-
2017
- 2017-11-20 CN CN201711160713.4A patent/CN109805940B/en active Active
Patent Citations (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04150837A (en) * | 1990-10-16 | 1992-05-25 | Nec San-Ei Instr Co Ltd | Blood sugar measuring apparatus |
| JP2007000517A (en) * | 2005-06-27 | 2007-01-11 | National Institute Of Advanced Industrial & Technology | Needle-integrated biosensor |
| CN1973768A (en) * | 2005-11-28 | 2007-06-06 | 中国科学院电子学研究所 | Non-invasive blood sugar instrument for closed-loop insulin injection |
| US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
| CN101377192A (en) * | 2007-08-30 | 2009-03-04 | 研能科技股份有限公司 | Fluid delivery device |
| US20100262117A1 (en) * | 2007-11-02 | 2010-10-14 | University Of Virginia Patent Foundation | Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing |
| CN101550925A (en) * | 2008-03-31 | 2009-10-07 | 研能科技股份有限公司 | Fluid transporting device with a plurality of dual-cavity actuating structures |
| US20120046651A1 (en) * | 2009-04-17 | 2012-02-23 | Uwe Beyer | Medical device for glucose monitoring or regulation |
| US20110105952A1 (en) * | 2009-10-30 | 2011-05-05 | Seventh Sense Biosystems, Inc. | Relatively small devices applied to the skin, modular systems, and methods of use thereof |
| CN104114224A (en) * | 2011-09-02 | 2014-10-22 | 加利福尼亚大学董事会 | Microneedle arrays for biosensing and drug delivery |
| US20130225956A1 (en) * | 2011-09-23 | 2013-08-29 | National Taipei University Of Technology | Transdermal Sensor |
| CN203110246U (en) * | 2011-10-28 | 2013-08-07 | 格雷斯海姆·雷根斯堡股份有限公司 | Devices for manufacturing objects with assistance of die-casting tool |
| TW201335483A (en) * | 2012-02-20 | 2013-09-01 | Microjet Technology Co Ltd | Fluid transmission device |
| US20150202418A1 (en) * | 2012-07-23 | 2015-07-23 | Renephra Limited | Microneedle-based devices and methods for the removal of fluid from a body |
| CN107073207A (en) * | 2014-08-01 | 2017-08-18 | 伯克顿迪金森公司 | Continuous glucose monitoring injection device |
| TWM537174U (en) * | 2016-01-29 | 2017-02-21 | Microjet Technology Co Ltd | Miniature fluid control device |
| CN205626630U (en) * | 2016-03-11 | 2016-10-12 | 成都市亿泰科技有限公司 | Portable injection device of intelligence insulin based on cloud calculates |
| CN106390277A (en) * | 2016-09-28 | 2017-02-15 | 成都市亿泰科技有限公司 | Pressure-controlled flexible microneedle drug delivery system |
| CN208492114U (en) * | 2017-11-20 | 2019-02-15 | 研能科技股份有限公司 | Blood sugar monitoring control system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109805940B (en) | 2022-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7198042B2 (en) | blood glucose meter | |
| JP7182996B2 (en) | blood glucose monitoring control system | |
| CA2451526C (en) | Gateway platform for biological monitoring and delivery of therapeutic compounds | |
| US20120022354A1 (en) | Medical device for measuring an analyte concentration | |
| EP2997988B1 (en) | Single needle integrated artificial pancreas | |
| JP2019093120A (en) | Wearable human being insulin injection liquid supply device | |
| CN112237656A (en) | Detect artifical pancreas equipment of infusion integral type closed loop | |
| CN101125086A (en) | Closed-loop automatic controlling insulin-injecting system | |
| RU2009119430A (en) | FLEXIBLE APPLICATOR FOR DELIVERY OF LIQUID AND MONITORING OF BODY ANALITIES | |
| CN208447604U (en) | Blood sugar detection apparatus | |
| JP2019080916A (en) | Liquid supply device for human insulin injection | |
| CN208492114U (en) | Blood sugar monitoring control system | |
| CN109805940A (en) | Blood sugar monitoring control system | |
| CN208405759U (en) | The liquid feed device of human insulin injection | |
| CN106110491A (en) | Administration device | |
| CN209074621U (en) | Blood sugar detection apparatus | |
| CN114432536A (en) | Integrated device and method for dynamic blood glucose monitoring and insulin injection fusion | |
| CN205626617U (en) | Attached pump control system device of insulin | |
| TWM560885U (en) | Blood sugar detection device | |
| CN109381194A (en) | A kind of safety painless intelligent blood glucose arrangement for detecting easy to carry | |
| TWM557589U (en) | Blood glucose monitoring and control system | |
| CN112237658B (en) | Integrated drug infusion device | |
| CN109718420A (en) | Wearable human insulin injects liquid feed device | |
| CN109805939A (en) | Blood sugar detection apparatus | |
| CN208678059U (en) | Wearable human insulin injects liquid feed device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |